Walgreens to Start Selling its Own OTC Naloxone Nasal Spray
Drug Topics
MAY 15, 2024
The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.
Drug Topics
MAY 15, 2024
The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.
Pharmacy Times
MAY 17, 2024
Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 16, 2024
There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and graphs depicting the diversity of the medical workforce. But as of Thursday, there will be at least nine more. Thursday is graduation day for the first class of the nation’s only tribally affiliated medical school, the Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation.
Fierce Healthcare
MAY 17, 2024
The panel that worked on the report was made up of Big Tech players like Amazon, Google and Microsoft, as well as leaders such as Harvard Medical School, the Leapfrog Group and Kaiser Permanente.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 17, 2024
While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.
Pharmacy Times
MAY 15, 2024
Properly training staff and gaining stakeholder buy-in are crucial steps to successfully designing and launching a program to screen and address health-related social needs.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
MAY 15, 2024
NEW YORK CITY—Uber Health will begin rolling out a new solution designed for caregivers this summer, the company announced at its annual product event Wednesday. | Uber Caregiver will allow care-receivers to add a caregiver to their Uber profile so they can see and spend their health benefits on eligible services, request rides to doctor’s appointments or order groceries.
Drug Topics
MAY 14, 2024
Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?
Pharmacy Times
MAY 15, 2024
Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.
STAT
MAY 15, 2024
WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 14, 2024
Facing the wrath of upset investors following its first quarter earnings, CVS Health has promised to value margins over members going forward. | CVS Health is reassessing its Medicare Advantage business and weighing the possibility of exiting certain markets as it looks to get its margins under control.
Drug Topics
MAY 14, 2024
A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.
Pharmacy Times
MAY 17, 2024
Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.
STAT
MAY 17, 2024
SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MAY 15, 2024
U.S. | Senators Sheldon Whitehouse and Bill Cassidy want to reform how primary care providers get paid through Medicare, and they also want to hear from the healthcare industry about the best way to do it.
Drug Topics
MAY 16, 2024
Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, sat down with Drug Topics to discuss his joint business venture.
Pharmacy Times
MAY 15, 2024
The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.
STAT
MAY 14, 2024
WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food. Scott Gottlieb, the commissioner of the Food and Drug Administration at the time, grinned widely as he held liquid egg whites and a carton of eggs.
Fierce Healthcare
MAY 13, 2024
The gap between insurance plans and Medicare's payments to hospitals for inpatient and outpatient services widened over the course of just a couple of years, a new study from RAND Corporation | A new report from RAND Corporation highlighted just how much more employers and private insurers are paying hospitals for inpatient and outpatient services.
Drug Topics
MAY 17, 2024
Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.
Pharmacy Times
MAY 17, 2024
Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.
STAT
MAY 16, 2024
As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control their child’s asthma. At least seven children have died due to uncontrolled asthma this year in the Philadelphia region, a dramatic increase from prior years.
pharmaphorum
MAY 13, 2024
Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy. The option fee could be followed by another up to $2.1 billion in potential milestones if Takeda takes global rights to the programme, currently headed by ACI-24.060 which is in a phase 1b/2 trial with new data due in the next few weeks.
Drug Topics
MAY 13, 2024
In Germany, data live in the cloud, patients can fill prescriptions at any pharmacy, and the wholesale price of semaglutide (Ozempic) is a fraction of the cost.
Pharmacy Times
MAY 14, 2024
Corticophobia is defined as a phobia of topical corticosteroids due to negative feelings or beliefs, which can come from misinformation about the long-term effects.
STAT
MAY 13, 2024
Reluctance among dairy farmers to report H5N1 bird flu outbreaks within their herds or allow testing of their workers has made it difficult to keep up with the virus’s rapid spread , prompting federal public health officials to look to wastewater to help fill in the gaps. On Monday, the Centers for Disease Control and Prevention is expected to unveil a public dashboard tracking influenza A viruses in sewage that the agency has been collecting from 600 wastewater treatment sites around the
Fierce Healthcare
MAY 17, 2024
Inequities in mental health across the U.S. | ED overutilization, exacerbated comorbidities and lost productivity will drive trillions in "avoidable and unnecessary expenses" should inequities in mental health access and outcomes remain unchecked.
Drug Topics
MAY 15, 2024
Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.
Pharmacy Times
MAY 16, 2024
Hepatitis Awareness Month is designed to raise awareness of viral hepatitis and promote testing and vaccination while decreasing the stigma against the virus.
STAT
MAY 17, 2024
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down. But HIV scientists are nothing if not resilient, and used to trying one new approach after another.
Fierce Pharma
MAY 13, 2024
Another attempt at improving upon AstraZeneca’s Imfinzi in stage 3, unresectable non-small cell lung cancer (NSCLC) has gone up in flames. | Following AstraZeneca's setback in attempting to improve upon Imfinzi's efficacy in unresectable stage 3 lung cancer, a Bristol Myers Squibb endeavor has gone up in flames, as well. Now, market watchers are turning their attention to upcoming readouts from Merck & Co. and Roche.
Drug Topics
MAY 13, 2024
Altuviiio was first granted approval by the FDA in February 2023.
Pharmacy Times
MAY 13, 2024
The data were previously presented at the Multilateral Initiative on Malaria 8th Pan-African Malaria Conference and have been submitted for regulatory review.
STAT
MAY 17, 2024
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived at a point where they could read, write, and edit any sequence of DNA. But composing whole genes or even whole genomes from scratch — that was something only evolution could do. A few years later, not long after helping to launch the Arc Institute, a nonprofit research center in the Bay Area, molecular engineer Patrick Hsu wondered if it was possible to imitate the forces of evolution
Let's personalize your content